A pharmacy, physician practice, or hospital that dispenses controlled substances from more than one address cannot rely on a single DEA registration to cover both. Under 21 U.S.C. 822(e) and 21 CFR 1301.12, a separate registration is required for each principal place of business or professional practice, tied to the physical location rather than to the corporate entity, the pharmacist-in-charge, or a registration the same owner already holds down the street. A registrant that opens a second location, relocates, or begins dispensing from an address DEA has not separately registered is operating that location without authority, exposure that can range from a delayed opening to an administrative action against a registration the pharmacy already holds elsewhere.
One Registration Per Location
The statute requires a separate registration at each principal place of business or professional practice where an applicant manufactures, distributes, or dispenses controlled substances, and DEA's implementing regulation restates that rule for every location where such substances are manufactured, distributed, imported, exported, or dispensed. DEA's own registration guidance confirms the same reading for practitioners who see patients at more than one office: the requirement attaches to each address, not to the individual or the entity. One consequence follows directly from that rule: the biennial inventory and the underlying inventory reconciliation that supports it must be kept and current at each separately registered location, not consolidated at a headquarters or a different store.
Moving Or Adding A Location
A pharmacy relocating within the same state can typically request a modification of its existing registration through DEA's registration center, but DEA will not process the change until the registrant holds an approved state license for the new address, and the modification must be approved before controlled substances move with it. Opening a second storefront is a different event, a new principal place of business requiring its own DEA Form 224 application, registration number, and review under the public interest factors that govern any first-time application, a process our companion analysis of DEA Registration Denials and the Public Interest Factors examines in more depth. Dispensing from a new address before that approval arrives can draw an immediate suspension order where DEA sees imminent danger to public health, or a broader order to show cause reaching registrations the pharmacy holds elsewhere. A registrant facing that kind of question from DEA should not sign a surrender of any registration before counsel reviews it, a risk our guidance on DEA voluntary surrender forms explains.
The Narrow Exceptions Under 1301.12(b)
Section 1301.12(b) exempts a short list of locations from the separate registration requirement. A warehouse storing controlled substances on a registrant's behalf falls outside the rule if it does not distribute directly to other locations or unregistered persons, a distinction that runs alongside a distributor's separate suspicious order monitoring obligations. A sales office is exempt if it holds no inventory beyond display samples, and a practitioner's second office is exempt only where prescriptions are written but controlled substances are never administered or dispensed there. Freight forwarders and emergency medical services agencies can operate additional locations once DEA receives written notice, and veterinarians may treat and dispense away from their registered practice within their licensing state. A registrant relying on any of these narrow exceptions should document the basis for it with the discipline covered in our companion piece on DEA recordkeeping and audit readiness. None of these exceptions reaches a retail pharmacy counter or a hospital pharmacy satellite, where the general rule controls.
A separate registration is required for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported, or dispensed.
Why Early Legal Counsel Is Critical
It is critical that pharmacies and practices retain experienced healthcare defense counsel before opening, relocating, or adding a location, or immediately upon receiving DEA correspondence questioning a registration's coverage. Early legal review can confirm which locations already fall under an existing registration, time a new application or modification correctly, and prevent a gap between when dispensing begins and when DEA approval actually arrives. Delaying that review can leave a pharmacy dispensing from an unregistered address without realizing it, exposure that grows the longer it goes uncorrected.
How Health Law Alliance Can Help
Health Law Alliance advises pharmacies, physician practices, and healthcare entities nationwide on DEA registration requirements, new location applications, modifications, and the show cause and suspension proceedings that follow a registration dispute. Our bench includes a former federal prosecutor and a former senior pharmacy benefit manager executive, background that shapes how we evaluate a registration question before it becomes an enforcement matter. If your pharmacy or practice is opening, moving, or adding a location and needs its DEA registration status reviewed, contact us for a free, confidential consultation.
